Alvarez, Rosa M. published the artcileOmipalisib inspired macrocycles as dual PI3K/mTOR inhibitors, Recommanded Product: 3-Bromo-6-iodo-imidazo[1,2-a]pyridine, the publication is European Journal of Medicinal Chemistry (2021), 113109, database is CAplus and MEDLINE.
Activation of the phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) signaling pathway occurs frequently in a wide range of human cancers and is a main driver of cell growth, proliferation, survival, and chemoresistance of cancer cells. Compounds targeting this pathway are under active development as anticancer therapeutics and some of them have reached advanced clin. trials or been approved by the FDA. Dual PI3K/mTOR inhibitors combine multiple therapeutic efficacies in a single mol. by inhibiting the pathway both upstream and downstream of AKT. Herein, we report our efforts on the exploration of novel small mol. macrocycles (MCXs) as dual PI3K/mTOR inhibitors. Macrocyclization is an attractive approach used in drug discovery, as the semi-rigid character of these structures could provide improved potency, selectivity and favorable pharmacokinetic properties. Importantly, this strategy allows access to new chem. space thus obtaining a better intellectual property position. A series of MCXs based on GSK-2126458, a known clin. PI3K/mTOR inhibitor is described. These mols. showed potent biochem. and cellular dual PI3K/mTOR inhibition, demonstrated strong antitumoral effects in human cancer cell lines, and displayed good drug-like properties. Among them, I presented remarkable selectivity against a panel of 468 kinases, high in vitro metabolic stability, and favorable pharmacokinetic parameters without significant CYP450 and h-ERG binding inhibition. This profile qualified this compound as a suitable candidate for future in vivo PK-PD and efficacy studies in mouse cancer models.
European Journal of Medicinal Chemistry published new progress about 1146615-52-2. 1146615-52-2 belongs to iodides-buliding-blocks, auxiliary class Other Aromatic Heterocyclic,Bromide,Iodide, name is 3-Bromo-6-iodo-imidazo[1,2-a]pyridine, and the molecular formula is C7H4BrIN2, Recommanded Product: 3-Bromo-6-iodo-imidazo[1,2-a]pyridine.
Referemce:
https://en.wikipedia.org/wiki/Iodide,
Iodide – an overview | ScienceDirect Topics – ScienceDirect.com